Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRWS Holdings Regulatory News (RWS)

Share Price Information for RWS Holdings (RWS)

Share Price is delayed by 15 minutes
Get Live Data
74.55    1.85 (2.54%)
Bid:
74.00
Ask:
75.60
Spread: 1.60 (2.162%)
Market Cap: £276.70m
RWS Live PriceLast checked at - London Stock Exchange

Intraday RWS Holdings Share Chart

Form 8.3 - RWS Holdings Plc

25 Sep 2020 16:07

Form 8.3 - RWS Holdings Plc

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:OCTOPUS INVESTMENTS LTD
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeRWS Holdings plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure24/09/2020
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary 1p
InterestsShort positions
 Number%Number%
(1) Relevant securities owned and/or controlled: 13,785,588 5.01  
(2) Cash-settled derivatives:     
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:13,785,5885.01  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/sale Number of securitiesPrice per unit
Ordinary 1pPurchase29,402£5.815 GBP

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
    

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
    

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:25/09/2020
Contact name:Romeo Olukotun
Telephone number:020 3142 4726

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
3rd Feb 20257:00 amRNSTotal Voting Rights
28th Jan 20252:06 pmRNSDirector/PDMR Shareholding
28th Jan 20252:04 pmRNSDirector/PDMR Shareholding
28th Jan 20252:01 pmRNSDirector/PDMR Shareholding
23rd Jan 20253:58 pmRNSOption Exercise, Admission and Total Voting Rights
9th Jan 20259:10 amRNSPublication of Annual Report and Notice of AGM
6th Jan 20259:00 amRNSAppointment of Director
2nd Jan 20257:00 amRNSTotal Voting Rights
12th Dec 20247:00 amRNSFinal Results
2nd Dec 20247:00 amRNSTotal Voting Rights
26th Nov 20247:00 amRNSDirectorate Change
1st Nov 20247:00 amRNSTotal Voting Rights
31st Oct 202410:12 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSTrading Statement
1st Oct 20247:00 amRNSDirectorate Change
1st Oct 20247:00 amRNSTotal Voting Rights
24th Sep 20247:00 amRNSDirector/PDMR Shareholding
2nd Sep 20247:00 amRNSTotal Voting Rights
13th Aug 202411:15 amRNSHolding(s) in Company
1st Aug 20249:21 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTotal Voting Rights
21st Jun 20249:58 amRNSDirector/PDMR Shareholding
12th Jun 20249:50 amRNSDirector/PDMR Shareholding
12th Jun 20247:00 amRNSHalf-year Report
3rd Jun 20247:00 amRNSTotal Voting Rights
23rd May 20247:00 amRNSDirectorate Change
1st May 20247:00 amRNSTotal Voting Rights
23rd Apr 20247:00 amRNSTrading Statement
2nd Apr 20247:00 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTotal Voting Rights
23rd Feb 20247:00 amRNSHolding(s) in Company
22nd Feb 20241:01 pmRNSResult of AGM
22nd Feb 20247:00 amRNSClosing of Share Repurchase Programme
22nd Feb 20247:00 amRNSAGM Statement
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20249:33 amRNSHolding(s) in Company
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.